Details of the Drug
General Information of Drug (ID: DMUJ18P)
Drug Name |
N-methyl-1-(2-thiophen-2-ylphenyl)methanamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-Methyl-N-(2-thien-2-ylbenzyl)amine; 852180-66-6; N-methyl-1-(2-thiophen-2-ylphenyl)methanamine; CHEMBL549343; N-Methyl-2-thien-2-ylbenzylamine; N-methyl-1-(2-(thiophen-2-yl)phenyl)methanamine; AC1OEOYY; CTK5F4550; DTXSID00427632; MolPort-000-143-044; HMS3604E04; ZINC3880928; SBB093177; BDBM50294171; AKOS010337666; RP04434; DB07196; n-methyl-n-(2-thiophen-2-ylbenzyl)amine; methyl[(2-(2-thienyl)phenyl)methyl]amine; KB-204244; KB-302285; RT-014485; Benzenemethanamine,N-methyl-2-(2-thienyl)-; Y4269; Benzenemethanamine, N-methyl-2-(2
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 203.31 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||